RecruitingNCT04664192
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
Sponsor
Baylor Research Institute
Enrollment
100 participants
Start Date
Jun 4, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- All individuals aged 18 years and older
- Persons who have undergone lung transplantation at Baylor University Medical Center in the previous 10 years
- Individual is able to understand and sign the informed consent form
Exclusion Criteria5
- Significant documented anemia (hemoglobin <8 g/dL)
- Blood transfusions within past 3 weeks
- Active cancer (non-skin cancers)
- Enrollment against doctor recommendation
- Patient not able to provide informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERPatient Biospecimen Registry (observational and blood sampling)
Clinical data collected at every blood sample collection visit.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04664192
Related Trials
ICU Background Early Awareness for Critical deterioratiON
NCT071194111 location
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
NCT059227616 locations
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT0638842167 locations
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
NCT075126871 location
Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure
NCT042367261 location